FY 23 Prescription Drug Affordability Fund Assessment

FY 23 Assessment Due October 1, 2022

Due: October 1, 2022 (Payment, Exemption, and Waiver Requests)

Assessments for the FY 2023 Maryland Prescription Drug Affordability Fund have been mailed to each entity's address of record. If your entity does not receive an assessment by August 31, 2022, or if you have any other questions about the assessment process, please contact Board staff by e-mail at support.pdab@maryland.gov. For additional information, please consult the Frequently Asked Questions form (last updated 08/16/2022).

How to Pay (electronic payment is preferred)

You may pay the assessment by ACH transfer, wire transfer, or check.

Payment by ACH is encouraged. Please e-mail payment.pdab@maryland.gov. for ACH and wire transfer instructions.

If paying by check, make checks payable to the “Maryland Prescription Drug Affordability Board." Please provide the PDAB vendor ID number and “FY 2023 PDAB Fund" or enclose a copy of the assessment, and mail to:

Maryland Prescription Drug Affordability Board
16900 Science Drive, Suite 112-114
Bowie, MD 20715
Due to limited hours due to COVID, we recommend mailing through the United States Postal Service (USPS).

Contact Information/Change of Address

It is the responsibility of the assessed entity to provide the PDAB with correct contact information and to provide PDAB with updated contact information in a timely manner
Form

Waivers
Waiver Form
Business Certification Form

Exemptions
Exemption Form
Business Certification Form

Resources
FAQ
Statutory Provisions